{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T01:09:12Z","timestamp":1785114552569,"version":"3.55.0"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T00:00:00Z","timestamp":1614816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>We aimed to study the clinical utility of serum lipoprotein-associated phospholipase A2 (Lp-PLA2) in acute ischemic stroke (AIS) with cerebral artery stenosis (CAS). We included 200 AIS patients and 90 healthy controls in this study. AIS patients were classified into three subgroups depending on the severity of CAS. They were also classified based on the stability of the carotid plaques. Spearman correlation analysis was performed to determine the correlation relationship between the level of Lp-PLA2 and neurologic injury. Binary logistic regression analysis was performed to determine the independent risk factors for AIS. Receiver operating characteristic (ROC) analysis was performed to assess the diagnostic value of Lp-PLA2 for AIS and for the degree of CAS. We found that the serum level of Lp-PLA2 in AIS patients was significantly higher than that in the control group. Lp-PLA2 was further identified as an independent risk factor for AIS (<jats:italic>p<\/jats:italic> = 0.001, OR = 1.057). In addition, serum Lp-PLA2 level was the highest in AIS patients with severe CAS or occlusion. Lp-PLA2 level was higher in AIS patients with unstable plaques and in AIS patients with moderate to severe neurological injury. Lp-PLA2 level was positively correlated with National Institutes of Health Stroke Scale (NIHSS) score (<jats:italic>r<\/jats:italic> = 0.335, <jats:italic>p<\/jats:italic> = 0.001). We found that the optimal cut-off value for Lp-PLA2 level was 123.365 ng\/ml, at which the sensitivity and specificity for the diagnosis of ACI were 74.5 and 86.7%, respectively, and the area under ROC curve (AUC) was 0.892. Similarly, the optimal value for Lp-PLA2 level was 136.46 ng\/ml, at which the sensitivity and specificity for the diagnosis of the presence of moderate to severe artery stenosis or occlusion were 79.6 and 95.2%, respectively, and the AUC was 0.938. The ROC curve indicated that serum Lp-PLA2 level has an excellent diagnostic value for AIS and severe stenosis. Based on these results we conclude that Lp-PLA2 could be a potential biomarker to complement the current imaging methods in the prediction and diagnosis of AIS. An elevated Lp-PLA2 level is also correlated with carotid plaque instability, severe neurological injury and cerebrovascular stenosis. Future longitudinal studies are needed to determine whether there is a causative relationship between Lp-PLA2 and AIS.<\/jats:p>","DOI":"10.3389\/fneur.2021.642483","type":"journal-article","created":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T07:16:50Z","timestamp":1614842210000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Clinical Utility of the Serum Level of Lipoprotein-Related Phospholipase A2 in Acute Ischemic Stroke With Cerebral Artery Stenosis"],"prefix":"10.3389","volume":"12","author":[{"given":"Jing","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongwu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Qun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,3,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1159\/000441083","article-title":"Methods for estimating the global burden of cerebrovascular diseases","volume":"45","author":"Roth","year":"2015","journal-title":"Neuroepidemiology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1159\/000438779","article-title":"The latest information on intracranial atherosclerosis: diagnosis and treatment","volume":"4","author":"Koo","year":"2015","journal-title":"Interv Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.06.033","article-title":"Association between cerebral arterial stiffness and large artery atherosclerosis in acute ischemic stroke","volume":"27","author":"Fu","year":"2018","journal-title":"J Stroke Cerebrovasc Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e223","DOI":"10.1016\/j.wneu.2018.01.026","article-title":"Carotid atherosclerotic plaque features in patients with acute ischemic stroke","volume":"112","author":"Sun","year":"2018","journal-title":"World Neurosurg"},{"key":"B5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1161\/01.ATV.0000251503.35795.4f","article-title":"Biomarkers of atherosclerotic plaque instability and rupture","volume":"27","author":"Koenig","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S1567-5688(02)00045-4","article-title":"Inflammation, bioactive lipids and atherosclerosis: potential roles of a lipoprotein-associated phospholipase A2, platelet activating factor-acetylhydrolase","volume":"3","author":"Tselepis","year":"2002","journal-title":"Atheroscler Suppl"},{"key":"B7","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.bbalip.2009.02.015","article-title":"The role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma","volume":"1791","author":"Tellis","year":"2009","journal-title":"Biochim Biophys Acta."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1016\/S0140-6736(10)60319-4","article-title":"Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies","volume":"375","author":"Thompson","year":"2010","journal-title":"Lancet"},{"key":"B9","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/ncpcardio0321","article-title":"Lipoprotein-associated phospholipase A2 as a biomarker for coronary disease and stroke","volume":"2","author":"Caslake","year":"2005","journal-title":"Nat Clin Pract Cardiovasc Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.amjcard.2008.04.017","article-title":"Lipoprotein-associated phospholipase A2 and risk of stroke","volume":"101","author":"Gorelick","year":"2008","journal-title":"Am J Cardiol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1097\/WNR.0000000000000765","article-title":"The elevated lipoprotein-associated phospholipase A2 activity is associated with the occurrence and recurrence of acute cerebral infarction","volume":"28","author":"Wei","year":"2017","journal-title":"Neuroreport"},{"key":"B12","doi-asserted-by":"publisher","first-page":"666","DOI":"10.3760\/cma.j.issn.1006-7876.2018.09.004","article-title":"Chinese guidelines for diagnosis and treatment of acute ischemic stroke 2018","volume":"51","year":"2018","journal-title":"Chin J Neurol."},{"key":"B13","first-page":"1026","article-title":"The NIHSS score and its components can predict cortical stroke","volume":"2","author":"Sartor","year":"2013","journal-title":"J Neurol Disord Stroke."},{"key":"B14","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1111\/ene.13251","article-title":"Aspiration and dysphagia screening in acute stroke-the gugging swallowing screen revisited","volume":"24","author":"Warnecke","year":"2017","journal-title":"Eur J Neurol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1161\/01.STR.22.6.711","article-title":"Methods, patient characteristics, and progress","volume":"22","year":"1991","journal-title":"Stroke"},{"key":"B16","doi-asserted-by":"publisher","first-page":"544","DOI":"10.14336\/AD.2018.0820","article-title":"The prognostic value of serum cytokines in patients with acute ischemic stroke","volume":"10","author":"Li","year":"2019","journal-title":"Aging Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.3390\/ijms17121967","article-title":"Update on inflammatory biomarkers and treatments in ischemic stroke","volume":"17","author":"Bonaventura","year":"2016","journal-title":"Int J Mol Sci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.coph.2005.11.008","article-title":"Role of lipoprotein-associated phospholipase A2 in atherosclerosis and its potential as a therapeutic target","volume":"6","author":"Macphee","year":"2006","journal-title":"Curr Opin Pharmacol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.cca.2019.05.017","article-title":"Serum lipoprotein-associated phospholipase A2 as a promising prognostic biomarker in association with 90-day outcome of acute intracerebral hemorrhage","volume":"495","author":"Bian","year":"2019","journal-title":"Clin Chim Acta."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1007\/s00380-019-01403-3","article-title":"Association between serum lipoprotein-associated phospholipase A2, ischemic modified albumin and acute coronary syndrome: a cross-sectional study","volume":"34","author":"Yang","year":"2019","journal-title":"Heart Vessels."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1212\/WNL.0000000000001938","article-title":"Association of Lp-PLA2-A and early recurrence of vascular events after TIA and minor stroke","volume":"85","author":"Lin","year":"2015","journal-title":"Neurology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e277","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.11.024","article-title":"Lipoprotein-associated phospholipase A2 during the hyperacute stage of ischemic and hemorrhagic strokes","volume":"23","author":"Rosso","year":"2014","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"B23","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1161\/01.CIR.0000154553.12214.CD","article-title":"Lipoprotein-associated phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke: the Rotterdam Study","volume":"111","author":"Oei","year":"2005","journal-title":"Circulation"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1161\/01.ATV.0000244681.72738.bc","article-title":"Lipoprotein-associated phospholipase A2 protein expression in the natural progression of human coronary atherosclerosis","volume":"26","author":"Kolodgie","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1001\/archinte.166.19.2073","article-title":"High-sensitivity C-reactive protein, lipoprotein-associated phospholipase A2, and outcome after ischemic stroke","volume":"166","author":"Elkind","year":"2006","journal-title":"Arch Intern Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1111\/j.1747-4949.2012.00860.x","article-title":"Improvement in stroke risk prediction: role of C-reactive protein and lipoprotein-associated phospholipase A2 in the women's health initiative","volume":"9","author":"Wassertheil-Smoller","year":"2014","journal-title":"Int J Stroke."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e83393","DOI":"10.1371\/journal.pone.0083393","article-title":"Lipoprotein-associated phospholipase A2 is associated with atherosclerotic stroke risk: the Northern Manhattan Study","volume":"9","author":"Katan","year":"2014","journal-title":"PLoS ONE"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1007\/s10072-018-3474-3","article-title":"Relation between lipoprotein-associated phospholipase A2 mass and incident ischemic stroke severity","volume":"39","author":"Zhou","year":"2018","journal-title":"Neurol Sci"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/01616412.2018.1493850","article-title":"Lp-PLA2 as a risk factor of early neurological deterioration in acute ischemic stroke with TOAST type of large arterial atherosclerosis","volume":"41","author":"Wang","year":"2019","journal-title":"Neurol Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1161\/CIRCULATIONAHA.108.771899","article-title":"Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque","volume":"118","author":"Serruys","year":"2008","journal-title":"Circulation"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1161\/ATVBAHA.112.249854","article-title":"Evidence supporting a key role of Lp-PLA2-generated lysophosphatidylcholine in human atherosclerotic plaque inflammation","volume":"32","author":"Gon\u00e7alves","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1161\/01.ATV.0000160551.21962.a7","article-title":"Role of lipoprotein-associated phospholipase A2 in atherosclerosis: biology, epidemiology, and possible therapeutic target","volume":"25","author":"Zalewski","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s11883-010-0158-8","article-title":"The role of lipoprotein-associated phospholipase a as a marker and potential therapeutic target in atherosclerosis","volume":"13","author":"Stewart","year":"2011","journal-title":"Curr Atheroscler Rep."},{"key":"B34","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.atherosclerosis.2007.12.001","article-title":"Lp-PLA2 activity and mass are associated with increased incidence of ischemic stroke: a population-based cohort study from Malm\u00f6, Sweden","volume":"200","author":"Persson","year":"2008","journal-title":"Atherosclerosis"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.642483\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T07:16:53Z","timestamp":1614842213000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.642483\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,4]]},"references-count":34,"alternative-id":["10.3389\/fneur.2021.642483"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2021.642483","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,4]]},"article-number":"642483"}}